STEPHANIE JACKSON: Open Payments
NPI 1073258380 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 24 payments from 11 companies in 2025. Trend: 2023 $181 · 2024 $574 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Lilly USA, LLC | 4 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Indivior Inc. | 1 | $20 |
Products named: VRAYLAR, AIRSUPRA, CAPLYTA, MOUNJARO, INGREZZA, Ozempic, LUTATHERA, NEXLETOL.
Industry payments across IL — which companies pay providers there.
